Safety of the long-term use of proton pump inhibitors
Open accessThe DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Abstract
The proton pump inhibitors (PPIs) as a class are remarkably safe and effective for persons with peptic ulcer disorders. Serious adverse events are extremely rare for PPIs, with case reports of interstitial nephritis with omeprazole, hepatitis with omeprazole and lansoprazole, and disputed visual disturbances with pantoprazole and omeprazole. PPI use is associated with the development of fundic gland polyps (FGP); stopping PPIs is associated with regression of FGP. In the absence of Helicobacter pylori infection, the long-term use of PPIs has not been convincingly proven to cause or be associated with the progression of pre-existing chronic gastritis or gastric atrophy or intestinal metaplasia. Mild/modest hypergastrinemia is a physiological response to the reduction in gastric acid secretion due to any cause. The long-term use of PPIs has not been convincingly proven to cause enterochromaffin-like cell hyperplasia or carcinoid tumors. PPIs increase the risk of community acquired pneumonia, but not of hospital acquired (nosocomial) pneumonia. There is no data to support particular care in prescribing PPI therapy due to concerns about risk of hip fracture with the long-term use of PPIs. Long-term use of PPIs does not lead to vitamin B12 deficiencies, except possibly in the elderly, or in persons with Zollinger-Ellison Syndrome who are on high doses of PPI for prolonged periods of time. There is no convincingly proven data that PPIs increase the risk of Clostridium difficile-associated diarrhea in persons in the community. The discontinuation of PPIs may result in rebound symptoms requiring further and even continuous PPI use for suppression of symptoms. As with all medications, the key is to use PPIs only when clearly indicated, and to reassess continued use so that long-term therapy is used judiciously. Thus, in summary, the PPIs are a safe class of medications to use long-term in persons in whom there is a clear need for the maintenance of extensive acid inhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Malfertheiner, P., Megraud, F., O'Morain, C., Bazzoli, F., El-Omar, E., Graham, D., Hunt, R., Rokkas, T., Vakil, N., Kuipers, E. J., et al. (2007) · Gut · doi:10.1136/gut.2006.101634 · Cited by 2,240
Total enteroscopy with a nonsurgical steerable double-balloon method
Yamamoto, H., Sekine, Y., Sato, Y., Higashizawa, T., Miyata, T., Iino, S., Ido, K., & Sugano, K. (2001) · Gastrointestinal Endoscopy · doi:10.1067/mge.2001.112181 · Cited by 1,289
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive Drugs
Laheij, R. J. F. (2004) · JAMA · doi:10.1001/jama.292.16.1955 · Cited by 877
The Medical Review Article: State of the Science
MULROW, C. D. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-3-485 · Cited by 856
Long-term sequelae of Helicobacter pylori gastritis
Kuipers, E. J., Peña, A. S., Festen, H. P. M., Meuwissen, S. G. M., Uyterlinde, A. M., Roosendaal, R., Pals, G., & Nelis, G. F. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91084-0 · Cited by 769
Kuipers, E. J., Lundell, L., Klinkenberg-Knol, E. C., Havu, N., Festen, H. P. M., Liedman, B., Lamers, C. B. H. W., Jansen, J. B. M. J., Dalenbäck, J., Snel, P., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604183341603 · Cited by 769
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
Juurlink, D. N., Gomes, T., Ko, D. T., Szmitko, P. E., Austin, P. C., Tu, J. V., Henry, D. A., Kopp, A., & Mamdani, M. M. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.082001 · Cited by 766
Systematic review of the risk of enteric infection in patients taking acid suppression
Leonard, J., Marshall, J. K., & Moayyedi, P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01275.x · Cited by 633
Dial, S. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040876 · Cited by 577
Stadtman, T. C. (1971) · Science · doi:10.1126/science.171.3974.859 · Cited by 541
Klinkenberg-Knol, E. C., Nelis, F., Dent, J., Snel, P., Mitchell, B., Prichard, P., Lloyd, D., Havu, N., Frame, M. H., Romàn, J., et al. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70135-1 · Cited by 534
Balancing the strengths of systematic and narrative reviews
Collins, J. A., & Fauser, B. C. J. M. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmh058 · Cited by 510
Calcium Absorption and Achlorhydria
Recker, R. R. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507113130202 · Cited by 502
Mylonaki, M., Fritscher-Ravens, A., & Swain, P. (2003) · Gut · doi:10.1136/gut.52.8.1122 · Cited by 477
Use of proton pump inhibitors and risk of osteoporosis-related fractures
Targownik, L. E., Lix, L. M., Metge, C. J., Prior, H. J., Leung, S., & Leslie, W. D. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071330 · Cited by 436
O’Connell, M. B., Madden, D. M., Murray, A. M., Heaney, R. P., & Kerzner, L. J. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.02.007 · Cited by 405
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0021-7 · Cited by 372
Reimer, C., Søndergaard, B., Hilsted, L., & Bytzer, P. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.058 · Cited by 356
Gulmez, S. E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.950 · Cited by 341
Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea
Cunningham, R., Dale, B., Undy, B., & Gaunt, N. (2003) · Journal of Hospital Infection · doi:10.1016/s0195-6701(03)00088-4 · Cited by 331
Long-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth, and gastritis
Lamberts, R., Creutzfeldt, W., Strüber, H. G., Brunner, G., & Solcia, E. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90344-c · Cited by 323
Proton-Pump Inhibitor Use and the Risk for Community-Acquired Pneumonia
Sarkar, M., Hennessy, S., & Yang, Y.-X. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-6-200809160-00005 · Cited by 301
Omeprazole: An Updated Review of its Pharmacology and Therapeutic Use in Acid-Related Disorders
McTavish, D., Buckley, M. M.-T., & Heel, R. C. (1991) · Drugs · doi:10.2165/00003495-199142010-00008 · Cited by 282
Increased risk of fundic gland polyps during long‐term proton pump inhibitor therapy
JALVING, M., KOORNSTRA, J. J., WESSELING, J., BOEZEN, H. M., DE JONG, S., & KLEIBEUKER, J. H. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03127.x · Cited by 269
Sites of Reaction of the Gastric H,K-ATPase with Extracytoplasmic Thiol Reagents
Besancon, M., Simon, A., Sachs, G., & Shin, J. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22438 · Cited by 259
Dubberke, E. R., Reske, K. A., Yan, Y., Olsen, M. A., McDonald, L. C., & Fraser, V. J. (2007) · Clinical Infectious Diseases · doi:10.1086/523582 · Cited by 254
Omeprazole Therapy Causes Malabsorption of Cyanocobalamin (Vitamin B12)
Marcuard, S. P., Albernaz, L., & Khazanie, P. G. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-3-199402010-00006 · Cited by 251
Laine, Ahnen, Mcclain, Solcia, & Walsh (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00768.x · Cited by 247
Clinical Endocrinology and Metabolism
(2023) · Clinical Endocrinology and Metabolism · doi:10.31579/2834-8761/cem · Cited by 242
Aseeri, M., Schroeder, T., Kramer, J., & Zackula, R. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01975.x · Cited by 236
Review article: proton pump inhibitors and bacterial overgrowth
WILLIAMS, C., & McCOLL, K. E. L. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02707.x · Cited by 221
Kuipers, E. J., Nelis, G. F., Klinkenberg-Knol, E. C., Snel, P., Goldfain, D., Kolkman, J. J., Festen, H. P. M., Dent, J., Zeitoun, P., Havu, N., et al. (2004) · Gut · doi:10.1136/gut.53.1.12 · Cited by 220
Theisen, J., Nehra, D., Citron, D., Johansson, J., Hagen, J. A., Crookes, P. F., DeMeester, S. R., Bremner, C. G., DeMeester, T. R., & Peters, J. H. (2000) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(00)80032-3 · Cited by 217
Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors
Blume, H., Donath, F., Warnke, A., & Schug, B. S. (2006) · Drug Safety · doi:10.2165/00002018-200629090-00002 · Cited by 216
Fitton, A., & Wiseman, L. (1996) · Drugs · doi:10.2165/00003495-199651030-00012 · Cited by 205
Ohkusa, T., Fujiki, K., Takashimizu, I., Kumagai, J., Tanizawa, T., Eishi, Y., Yokoyama, T., & Watanabe, M. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-5-200103060-00010 · Cited by 205
Comparison of Omeprazole and Ranitidine for Stress Ulcer Prophylaxis
Levy, M. J., Seelig, C. B., Robinson, N. J., & Ranney, J. E. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018810325370 · Cited by 202
Wu, T.-T., Kornacki, S., Rashid, A., Yardley, J. H., & Hamilton, S. R. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199803000-00003 · Cited by 190
Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorová, I., Svoboda, P., Scheer, P., Doubek, J., Rehorkova, D., Bosakova, H., & Ochmann, J. (2004) · PubMed · Cited by 180
Termanini, B., Gibril, F., Sutliff, V. E., Yu, F., Venzon, D. J., & Jensen, R. T. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00087-4 · Cited by 176
Lack of effect of acid suppression therapy on gastric atrophy
Lundell, L., Miettinen, P., Myrvold, H. E., Pedersen, S. A., Thor, K., Andersson, A., Hattlebakk, J., Havu, N., Janatuinen, E., Levander, K., et al. (1999) · Gastroenterology · doi:10.1053/gast.1999.0029900319 · Cited by 172
Coyle, W. J. (2006) · Current Gastroenterology Reports · doi:10.1007/s11894-006-0050-4 · Cited by 171
Williams, Sercombe, Hamilton, & Pounder (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00418.x · Cited by 168
Effect of Proton Pump Inhibitors on Vitamins and Iron
McColl, K. E. L. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.45 · Cited by 159
Spencer, C. M., & Faulds, D. M. (1994) · Drugs · doi:10.2165/00003495-199448030-00007 · Cited by 149
Proton pump inhibitor therapy is a risk factor for Clostridium difficile ‐associated diarrhoea
YEARSLEY, K. A., GILBY, L. J., RAMADAS, A. V., KUBIAK, E. M., FONE, D. L., & ALLISON, M. C. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03015.x · Cited by 145
Serfaty-Lacrosnière, C., Wood, R. J., Voytko, D. A., Saltzman, J. R., Pedrosa, M. C., Sepe, T. E., & Russell, R. R. (1995) · Journal of the American College of Nutrition · doi:10.1080/07315724.1995.10718522 · Cited by 144
Long‐term use of proton pump inhibitors and vitamin B12 status in elderly individuals
DEN ELZEN, W. P. J., GROENEVELD, Y., DE RUIJTER, W., SOUVERIJN, J. H. M., LE CESSIE, S., ASSENDELFT, W. J. J., & GUSSEKLOO, J. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03601.x · Cited by 141
Consequences of Long‐Term Proton Pump Blockade: Insights from Studies of Patients with Gastrinomas
Jensen, R. T. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_378.x · Cited by 131
Cobalamin: a critical vitamin in the elderly
Wolters, M., Ströhle, A., & Hahn, A. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2004.04.047 · Cited by 130
Fundic gland polyps developing during omeprazole therapy.
El‐Zimaity, H. M. T., Jackson, F. W., & Graham, D. Y. (1997) · PubMed · Cited by 129
Martinez-Pellús, A., Merino, P., Bru, M., Conejero, R., Seller, G., Muñoz, C., Fuentes, T., González, G., & Alvarez, B. (1993) · Critical Care Medicine · doi:10.1097/00003246-199311000-00017 · Cited by 124
Changing Patterns of Helicobacter pylori Gastritis in Long‐Standing Acid Suppression
Moayyedi, P., Wason, C., Peacock, R., Walan, A., Bardhan, K., Axon, A. T. R., & Dixon, M. F. (2000) · Helicobacter · doi:10.1046/j.1523-5378.2000.00032.x · Cited by 122
Lack of effect of acid suppression therapy on gastric atrophy
Stolte, M., & Meining, A. G. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70447-1 · Cited by 120
Serum Iron, Ferritin, and Vitamin B12 During Prolonged Omeprazole Therapy
Koop, H., & Bachem, M. G. (1992) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199206000-00005 · Cited by 119
EFFECT OF CIMETIDINE ON SURVIVAL AFTER GASTRIC CANCER
Tønnesen, H., Bülow, S., Fischerman, K., Hjortrup, A., Pedersen, V. M., Svendsen, L. B., Knigge, U., Damm, P., Hesselfeldt, P., Pedersen, I. K., et al. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90743-x · Cited by 117
The continuing development of proton pump inhibitors with particular reference to pantoprazole
Huber, R., KOHL, B., Sachs, G. M., Senn‐Bilfinger, J., Simon, W. A., & Sturm, E. (1995) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1995.tb00394.x · Cited by 117
Vitamin B12 Levels During Prolonged Treatment With Proton Pump Inhibitors
Howden, C. W. (2000) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200001000-00006 · Cited by 116
Albumin, Length of Stay, and Proton Pump Inhibitors
Al-Tureihi, F. I. J., Hassoun, A., Wolf‐Klein, G. P., & Isenberg, H. D. (2005) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2005.01.003 · Cited by 116
A Hospital Outbreak of Diarrhea Due to an Emerging Epidemic Strain of Clostridium difficile
Kazakova, S. V. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.22.2518 · Cited by 116
Ruscin, J. M., Page, R. L., II, & Valuck, R. J. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.10325 · Cited by 115
Stolte, Meining, Schmitz, Alexandridis, & Seifert (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00310.x · Cited by 106
Yıldızdaş, D., Yapıcıoğlu, H., & Yılmaz, H. L. (2002) · Journal of Critical Care · doi:10.1053/jcrc.2002.36761 · Cited by 104
Effect of Omeprazole on Oral Iron Replacement in Patients with Iron Deficiency Anemia
Sharma, V. R., Brannon, M. A., & Carloss, E. A. (2004) · Southern Medical Journal · doi:10.1097/01.smj.0000110405.63179.69 · Cited by 102
Saltzman, J. R., Kemp, J. A., Golner, B. B., Pedrosa, M. C., Dallal, G. E., & Russell, R. M. (1994) · Journal of the American College of Nutrition · doi:10.1080/07315724.1994.10718452 · Cited by 100
Langtry, H. D., & Wilde, M. I. (1997) · Drugs · doi:10.2165/00003495-199754030-00010 · Cited by 100
Proton Pump Inhibitor Use and Enteric Infections
Dial, M. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.46 · Cited by 100
Effects of Very Long (up to 10 Years) Proton Pump Blockade on Human Gastric Mucosa
Lamberts, R., Brunner, G. H. G., & Solcia, E. (2001) · Digestion · doi:10.1159/000048863 · Cited by 96
Lundell, L. R., Havu, N., Miettinen, P. S., Myrvold, H. E., Wallin, L., Julkunen, R. J. K., Levander, K., Hatlebakk, J. G., Liedman, B., Lamm, M., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02792.x · Cited by 94
The Effect of Proton Pump-Inhibiting Drugs on Mineral Metabolism
Insogna, K. L. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.44 · Cited by 86
Schenk, B. E., Festen, H. P. M., Kuipers, E. J., Klinkenberg–Knol, E. C., & Meuwissen, S. G. M. (1996) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1996.27169000.x · Cited by 84
Gastric Endocrine Cells and Gastritis in Patients Receiving Long-Term Omeprazole Treatment
Solcia, E., Fiocca, R., Havu, N., Dalväg, A., & Carlsson, R. (2009) · Digestion · doi:10.1159/000200921 · Cited by 83
High-grade dysplasia in sporadic fundic gland polyps: a case report and review of the literature
Jalving, M., Koornstra, J. J., tz, J. M. G., van der Waaij, L. A., de Jong, S., Zwart, N., Karrenbeld, A., & Kleibeuker, J. H. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200311000-00013 · Cited by 83
Pharmacological Management of Gastro-Oesophageal Reflux Disease
Klinkenberg–Knol, E. C., Festen, H. P. M., & Meuwissen, S. G. M. (1995) · Drugs · doi:10.2165/00003495-199549050-00005 · Cited by 80
Sultan, N., Nazareno, J., & Gregor, J. C. (2008) · Canadian Journal of Gastroenterology · doi:10.1155/2008/821385 · Cited by 79
Simms, H. H., DeMaria, E., McDonald, L., Peterson, D., Robinson, A., & Burchard, K. W. (1991) · PubMed · Cited by 78
Regression of fundic gland polyps following acquisition of Helicobacter pylori
Watanabe, N., Seno, H., Nakajima, T., Yazumi, S., Miyamoto, S., Matsumoto, S., Itoh, T., Kawanami, C., Okazaki, K., & Chiba, T. (2002) · Gut · doi:10.1136/gut.51.5.742 · Cited by 78
Mortality study of 18 000 patients treated with omeprazole
Bateman, D. N., Colin-Jones, D., Hartz, S., Langman, M., Logan, R. F., Mant, J., Murphy, M., Paterson, K. R., Rowsell, R., Thomas, S., et al. (2003) · Gut · doi:10.1136/gut.52.7.942 · Cited by 78
Dockray, G. J. (2004) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.07.003 · Cited by 73
Varannes, S. B. D., Lévy, P., Lartigue, S., Dellatolas, F., LEMAIRE, M., & Galmiche, J. (1994) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1994.tb00293.x · Cited by 73
Labenz, J., Petersen, K., Rösch, W. H., et al. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01550.x · Cited by 73
Jayatilaka, S. G., Shakov, R., Eddi, R., Bakaj, G., Baddoura, W., & DeBari, V. A. (2007) · PubMed · Cited by 65
Pernicious anaemia as a risk factor for osteoporosis
Eastell, R., Vieira, N. E., Yergey, A. L., Wahner, H. W., Silverstein, M. N., Kumar, R., & Riggs, B. L. (1992) · Clinical Science · doi:10.1042/cs0820681 · Cited by 65
Small Bowel Bacterial Overgrowth in Symptomatic Older People: Can It Be Diagnosed Earlier?
Elphick, D. A., Chew, T. S., Higham, S. E., Bird, N., Ahmad, A., & Sanders, D. S. (2005) · Gerontology · doi:10.1159/000088704 · Cited by 64
Schenk, Kuipers, Klinkenberg‐Knol, Bloemena, E., Nelis, Festen, Jansen, J. B. �. �., Biemond, Lamers, & Meuwissen, S. G. M. (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00349.x · Cited by 64
Colitis Due toClostridium DifficileToxins: Underdiagnosed, Highly Virulent, and Nosocomial
Fordtran, J. S. (2006) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2006.11928114 · Cited by 56
Atrophic gastritis during long‐term omeprazole therapy affects serum vitamin B12 levels
Schenk, Kuipers, Klinkenberg‐Knol, Bloemena, E., Sandell, Nelis, Snel, Festen, & Meuwissen, S. G. M. (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00616.x · Cited by 56
Predicting Clostridium difficile Toxin in Hospitalized Patients With Antibiotic-Associated Diarrhea
Peled, N., Pitlik, S. D., Samra, Z., Kazakov, A., Bloch, Y., & Bishara, J. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/513723 · Cited by 56
Beaulieu, M., Williamson, D., Pichette, G., & Lachaine, J. (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/521664 · Cited by 54
Masubuchi, N., Li, A. P., & Okazaki, O. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(98)00031-3 · Cited by 50
Gastric Acid, Acid-Suppressing Drugs, and Bacterial Gastroenteritis
Alberto, L., Rodríguez, G., & Ruigómez, A. (1997) · Epidemiology · doi:10.1097/00001648-199709000-00016 · Cited by 48
Geboes, K., Dekker, W., Mulder, C. J. J., Nusteling, K., & (ON BEHALF OF THE DUTCH STUDY GROUP) (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01105.x · Cited by 47
Levine, A., Shevah, O., Shabat-Sehayek, V., et al. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02021.x · Cited by 45
Subsite-Specific Risk Factors for Esophageal and Gastric Adenocarcinoma
Crane, S. J., Locke, G. R., Harmsen, W. S., Diehl, N. N., Zinsmeister, A. R., Melton, L. J., Romero, Y., & Talley, N. J. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01234.x · Cited by 44
Singh, P. K. (2000) · World Journal of Gastroenterology · doi:10.3748/wjg.v6.i6.789 · Cited by 43
Parente, F., Sainaghi, M., Sangaletti, O., et al. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01192.x · Cited by 43
Acid Inhibition and Infections Outside the Gastrointestinal Tract
Vakil, N. B. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.47 · Cited by 43
Merchant, S. H., VanderJagt, T. J., Lathrop, S. L., & Amin, M. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213326.86992.98 · Cited by 42
Leighton, J. A., Sharma, V. K., Hentz, J. G., Musil, D., Malikowski, M., McWane, T. L., & Fleischer, D. E. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9350-7 · Cited by 40
Mitchell, S. L., & Rockwood, K. J. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00340-1 · Cited by 39
Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Mashiba, H., Sasaki, N., & Taniyama, K. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00834.x · Cited by 38
Helicobacter pylori infection and long term proton pump inhibitor therapy
McColl, K. E. L. (2003) · Gut · doi:10.1136/gut.53.1.5 · Cited by 36
Akhtar, A. J., & Shaheen, M. A. (2007) · PubMed · Cited by 35
Drug points: Ocular damage associated with proton pump inhibitors: Table 1
Schönhöfer, P. S., Werner, B., & Tröger, U. (1997) · BMJ · doi:10.1136/bmj.314.7097.1805 · Cited by 33
Portolés, A., Calvo, A., Terleira, A. I., et al. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006291624 · Cited by 33
Effects of 6–12 months of esomeprazole treatment on the gastric mucosa
Genta, R. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00268-5 · Cited by 32
Evidence based general practice.
Suárez-Varela, M. M. M., González, A. L., Bell, J., Guerola, M. T., Pérez-Benajas, A., & Carrión-Carrión, C. (1999) · European Journal of Epidemiology · doi:10.1023/a:1007609926935 · Cited by 30
Effect of pantoprazole on 24‐h intragastric pH and serum gastrin in humans.
Londong, W. (1994) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1994.tb00239.x · Cited by 30
Hip Fracture and Proton Pump Inhibitor Therapy: Balancing the Evidence for Benefit and Harm
Moayyedi, P., & Cranney, A. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02031.x · Cited by 29
A review of epidemiological studies on cancer in relation to the use of anti-ulcer drugs
Vecchia, C. L., & Tavani, A. (2002) · European Journal of Cancer Prevention · doi:10.1097/00008469-200204000-00002 · Cited by 29
McColl, K. E. L., Murray, L. S., & Gillen, D. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70444-6 · Cited by 27
Drug Interactions with Proton Pump Inhibitors
Unge, P., & Andersson, T. (1997) · Drug Safety · doi:10.2165/00002018-199716030-00003 · Cited by 26
Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer
on behalf of the British Stomach Cancer Group, Langman, M. J. S., Dunn, J., Whiting, J., Burton, A., Hallissey, M. T., Fielding, J. W. L., & Kerr, D. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690457 · Cited by 24
Omeprazole-Induced Interstitial Nephritis
Yip, D., Kovac, S., Jardine, M., HORVATH, J. S., & Findlay, M. P. N. (1997) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199709000-00011 · Cited by 24
Hauben, M., Horn, S., Reich, L., & Younus, M. (2007) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2006.11.004 · Cited by 23
Proton Pump Inhibitor Therapy and Hip Fracture Risk
Geller, J. L., & Adams, J. S. (2007) · JAMA · doi:10.1001/jama.297.13.1429-a · Cited by 15
Proton Pump Inhibitors and Helicobacter pylori Gastritis: Friends or Foes?
Kuipers, E. J. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_478.x · Cited by 14
Cited by
Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis
Janarthanan, S., Ditah, I., Adler, D. G., & Ehrinpreis, M. N. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.179 · Cited by 538
for the SIF-AIGO-FIMMG Group, Scarpignato, C., on behalf of the Italian Society of Pharmacology, T. I. A. O. H. G., Gatta, L., Zullo, A., & Blandizzi, C. (2016) · BMC Medicine · doi:10.1186/s12916-016-0718-z · Cited by 469
Ito, T., & Jensen, R. T. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0141-0 · Cited by 309
Thomson, M., Tringali, A., Dumonceau, J., Tavares, M., Tabbers, M. M., Furlano, R., Spaander, M., Hassan, C., Tzvinikos, C., Ijsselstijn, H., et al. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001408 · Cited by 290
Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions
Song, H., Zhu, J., & Lu, D. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010623.pub2 · Cited by 132
Metadata
- Authors
- Thomson, A. B.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2010
- Volume
- 16
- Issue
- 19
- Pages
- 2323
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2138543113
- Cited by
- 315
- References
- 119
- FWCI
- 29.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.